These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 7491382

  • 1. Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.
    Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ.
    Psychopharmacol Bull; 1995; 31(2):297-303. PubMed ID: 7491382
    [Abstract] [Full Text] [Related]

  • 2. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR, Salloum IM, Thase ME, Haskett RF, Daley DC, Jones-Barlock A, Upsher C, Perel JM.
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [Abstract] [Full Text] [Related]

  • 3. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Black A, Perel JM, Thase ME.
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine trial in suicidal depressed alcoholics.
    Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Thase ME, Ehler JG, Mann JJ.
    Psychopharmacol Bull; 1993; 29(2):195-9. PubMed ID: 8290665
    [Abstract] [Full Text] [Related]

  • 5. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [Abstract] [Full Text] [Related]

  • 7. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
    Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A.
    Arch Gen Psychiatry; 1997 Aug; 54(8):700-5. PubMed ID: 9283504
    [Abstract] [Full Text] [Related]

  • 8. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D.
    Depress Anxiety; 2002 Aug; 16(1):4-13. PubMed ID: 12203668
    [Abstract] [Full Text] [Related]

  • 9. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM.
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [Abstract] [Full Text] [Related]

  • 11. A controlled trial of fluoxetine in nondepressed patients with Huntington's disease.
    Como PG, Rubin AJ, O'Brien CF, Lawler K, Hickey C, Rubin AE, Henderson R, McDermott MP, McDermott M, Steinberg K, Shoulson I.
    Mov Disord; 1997 May; 12(3):397-401. PubMed ID: 9159735
    [Abstract] [Full Text] [Related]

  • 12. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.
    Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):439-42. PubMed ID: 17174460
    [Abstract] [Full Text] [Related]

  • 13. Desipramine treatment of alcoholism.
    Mason BJ, Kocsis JH.
    Psychopharmacol Bull; 1991 Mar 30; 27(2):155-61. PubMed ID: 1924663
    [Abstract] [Full Text] [Related]

  • 14. Patterns of improvement in depressive symptoms with fluoxetine treatment.
    Worthington J, Fava M, Davidson K, Alpert J, Nierenberg AA, Rosenbaum JF.
    Psychopharmacol Bull; 1995 Mar 30; 31(2):223-6. PubMed ID: 7491372
    [Abstract] [Full Text] [Related]

  • 15. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.
    Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N.
    Am J Psychiatry; 1995 Mar 30; 152(3):391-7. PubMed ID: 7864265
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
    Cornelius JR, Salloum IM, Haskett RF, Ehler JG, Jarrett PJ, Thase ME, Perel JM.
    Addict Behav; 1999 Mar 30; 24(1):111-4. PubMed ID: 10189977
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
    Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, Perel JM.
    Addict Behav; 2000 Mar 30; 25(2):307-10. PubMed ID: 10795957
    [Abstract] [Full Text] [Related]

  • 18. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC, Mauri MC, Girardi T, Panetta B.
    Int J Clin Pharmacol Res; 1990 Mar 30; 10(5):293-8. PubMed ID: 2079386
    [Abstract] [Full Text] [Related]

  • 19. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design.
    Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM.
    Psychopharmacol Bull; 1990 Mar 30; 26(1):85-90. PubMed ID: 2196631
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.
    Mason BJ, Kocsis JH, Ritvo EC, Cutler RB.
    JAMA; 1996 Mar 13; 275(10):761-7. PubMed ID: 8598592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.